Pseudoprogression in patients with glioblastoma: Assessment by using volume-weighted voxel-based multiparametric clustering of MR imaging data in an independent test set

Radiology

Volumn 275, Issue 3, 2015, Pages 792-802

  Park, Ji Eun ^a   Kim, Ho Sung ^a   Goh, Myeong Ju ^a   Kim, Sang Joon ^a   Kim, Jeong Hoon ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; BRAIN BLOOD VOLUME; CLASSIFIER; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; VOXEL BASED MORPHOMETRY; BRAIN TUMOR; COMPARATIVE STUDY; DISEASE COURSE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES;

BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84930841606     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14141414     Document Type: Article

References (23)

1. Chamberlain MC. Pseudoprogression in glioblastoma. J Clin Oncol 2008;26(26):4359; author reply 4359-4360.
2. Jensen RL. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009;92(3):317-335.
3. New P. Radiation injury to the nervous system. Curr Opin Neurol 2001;14(6):725-734.
4. Sugahara T, Korogi Y, Tomiguchi S, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000;21(5):901-909.
5. Suh CH, Kim HS, Choi YJ, Kim N, Kim SJ. Prediction of pseudoprogression in patients with glioblastomas using the initial and final area under the curves ratio derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. AJNR Am J Neuroradiol 2013;34(12):2278-2286.
6. Asao C, Korogi Y, Kitajima M, et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. AJNR Am J Neuroradiol 2005;26(6):1455-1460.
7. Fatterpekar GM, Galheigo D, Narayana A, Johnson G, Knopp E. Treatment-related change versus tumor recurrence in high-grade gliomas: a diagnostic conundrum - use of dynamic susceptibility contrast-enhanced (DSC) perfusion MRI. AJR Am J Roentgenol 2012;198(1):19-26.
8. Verma R, Zacharaki EI, Ou Y, et al. Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images. Acad Radiol 2008;15(8):966-977.
9. Hu X, Wong KK, Young GS, Guo L, Wong ST. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging 2011;33(2):296-305.
10. Jung V, Romeike BF, Henn W, et al. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumor cells. J Neuropathol Exp Neurol 1999;58(9):993-999.
11. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB. Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62(6):450-459.
12. Baek HJ, Kim HS, Kim N, Choi YJ, Kim YJ. Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas. Radiology 2012;264(3):834-843.
13. Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010;28(11):1963-1972.
14. Chung WJ, Kim HS, Kim N, Choi CG, Kim SJ. Recurrent glioblastoma: optimum area under the curve method derived from dynamic contrast-enhanced T1-weighted perfusion MR imaging. Radiology 2013;269(2):561-568.
15. Kim HS, Suh CH, Kim N, Choi CG, Kim SJ. Histogram analysis of intravoxel incoherent motion for differentiating recurrent tumor from treatment effect in patients with glioblastoma: initial clinical experience. AJNR Am J Neuroradiol 2014;35(3):490-497.
16. Cha J, Kim ST, Kim HJ, et al. Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis. AJNR Am J Neuroradiol 2014;35(7):1309-1317.
17. Hong X, Liu L, Wang M, et al. Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. Neuro-oncol 2014;16(6):856-867.
18. Lemasson B, Galbán CJ, Boes JL, et al. Diffusion-weighted MRI as a biomarker of tumor radiation treatment response heterogeneity: a comparative study of whole-volume histogram analysis versus voxel-based functional diffusion map analysis. Transl Oncol 2013;6(5):554-561.
19. Padhani AR, Miles KA. Multiparametric imaging of tumor response to therapy. Radiology 2010;256(2):348-364.
20. Hygino da Cruz LC Jr, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol 2011;32(11):1978-1985.
21. Kanungo T, Mount DM, Netanyahu NS, Piatko CD, Silverman R, Wu AY. An efficient k-means clustering algorithm: analysis and implementation. IEEE Trans Pattern Anal Mach Intell 2002;24(7):881-892.
22. Selvy PT, Palanisamy V, Purusothaman T. Performance analysis of clustering algorithms in brain tumor detection of MR images. Eur J Sci Res 2011;62(3):321-330.
23. Wu MN, Lin CC, Chang CC. Brain tumor detection using color-based k-means clustering segmentation. In: Third International Conference on Intelligent Information Hiding and Multimedia Signal Processing, 2007. IIHMSP 2007. Kaohsiung, Taiwan: IEEE, 2007; 245-250.